Abstract
The purpose of this study was to explore the composition and function of immune cell subsets at the single-cell level in the thymus and peripheral blood of patients with myasthenia gravis (MG). A total of 9701 and 23 846 cells, respectively, originated from the peripheral blood and thymus samples of two MG patients, and 6930 cells from the peripheral blood of two gender- and age-matched healthy controls (HCs) were selected for single-cell RNA-sequencing. Uniform manifold approximation and projection (UMAP), Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, Monocle3, and Velcyto were performed to analyze the composition, molecular and functional properties, and developmental trajectory of immune cell subsets. Four major cell populations of T cells, B cells, myeloid cells, and natural killer cells were identified, as well as their 15 cell subpopulations. An absolute predominance of T cells was found in the thymus and peripheral blood of MG patients, and the proportions of memory B cells in both plasma and thymus showed an increasing trend while the number of naïve B cells demonstrated a decreasing trend in MG patients compared with HCs. Besides, the monocytes in the peripheral blood of MG patients had the strongest interactions with other cells. Furthermore, CXCL, GAS, and CD30 signaling pathways were more enriched within MG peripheral blood. Our research clarifies the cellular heterogeneity in the pathogenesis of MG and characterizes the immune microenvironment of thymic tissues in MG patients.
Keywords: peripheral blood, thymus
Single-cell RNA-seq of thymus and blood cells in MG
Introduction
Myasthenia gravis (MG) is an autoimmune disease that damages neuromuscular transmission and is mediated by acetylcholine receptor (AChR) antibody, with a global prevalence of 12.4 people per 100 000 population (1). The main clinical manifestations of MG are partial or systemic skeletal muscle weakness and fatigue, which can be manifested as ptosis, dysphagia, weakness in speech, and even respiratory failure caused by respiratory muscle involvement, which has a great impact on the quality of life and even life span of patients (2, 3).
Studies have found that the thymus is the main site where AChR antibodies are produced, and thymic dysfunction is an important cause of the above symptoms of MG (4). Therefore, about 80% of MG patients suffer from thymic hyperplasia and about 20% suffer from thymic tumors (5, 6). After thymectomy, the symptoms of MG patients were significantly improved and the level of AChR antibody decreased significantly (7). From the perspective of thymic pathology, it can be found that compared with normal thymus, the thymic medulla of early-onset MG is filled with a large number of B cells, lymphoid follicles, activated T cells and high endothelial vein dilatation, showing a state of inflammation (8). In the presence of MG, the immune function of the thymus with abnormal structure will inevitably change, the normal immune dynamic balance of the human body will be out of balance, and MG patients have an increased incidence of other autoimmune diseases, such as thyroid disease, rheumatoid arthritis, and systemic lupus erythematosus (9, 10).
Although the main types of immune cells involved in the pathogenesis of MG have been elucidated (11, 12), the characteristics and interactions of these cells at the single-cell level in thymus and peripheral blood are still lacking. In addition, although AChR antibodies are essential for MG, levels of AChR antibodies do not correlate with the severity of the disease or the effectiveness of treatment, indicating that we still lack understanding of the underlying mechanisms of the disease.
Single-cell RNA-sequencing (scRNA-seq) has provided unprecedented opportunities to uncover the cellular heterogeneity at high resolution. A previous study constructed a comprehensive map of thymoma by scRNA-seq and identified the ectopic expression of neuromuscular molecules in MG-type thymoma (13). There are also studies on the function of immune cells in peripheral blood of patients with MG by the single-cell transcriptome technique (14, 15). In our current study, we performed scRNA to profile immune cell subsets from peripheral blood mononuclear cells (PBMCs) and thymic tissues of MG patients, as well as gender- and age-matched healthy controls (HCs). Our study depicted the transcriptional profiles of immune cells of thymus tissue and PBMCs from MG patients at the single-cell level, characterized the cytopathic mechanisms through the differences in the composition of immune cell subpopulations, cellular differentiation and development, intercellular communication networks, and cellular functions, and found that there is significant transcriptional heterogeneity in the immune microenvironment of MG patients, which will provide support for the elucidation of MG pathogenesis, and the search for new diagnostic and therapeutic targets.
Methods
Patients
This study recruited two MG patients from the department of thoracic surgery of Beijing Hospital (Beijing, China), and two age- and sex-matched HCs. The diagnostic criteria of MG were as follows: (i) clinical symptoms; (ii) neostigmine test result; (iii) repetitive nerve electrical stimulation; and (iv) serum autoantibody levels.
Participants were excluded if they had (i) any other neuromuscular conduction disorders, such as muscular dystrophy syndrome; (ii) autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, etc.; (iii) neuromuscular conduction disorders caused by long-term use of certain anticholinesterase drugs or antiarrhythmic drugs (such as β-blockers); (iv) other malignant diseases, acute and chronic inflammation, and/or hepatorenal dysfunction; or (v) MG caused by other causes, such as congenital muscular dystrophy.
The data of HC thymus donor were obtained from: https://developmental.cellatlas.io/studies/thymus-development#datasets.
Sample collection and single-cell suspension preparation
Thymic tissue and venous blood from the same donors were collected from two patients with MG within 24 h after admission. Thymic tissue samples were minced into approximately 1 mm3 fragments on ice using sterile surgical blades. The minced tissue was then subjected to enzymatic digestion by incubation in 0.25% (w/v) trypsin-EDTA solution at 37°C for 20 min with constant agitation. Following digestion, the resulting cell suspension was filtered through a 70 µm cell strainer to remove undigested debris. Both the thymic tissue and venous blood of the above two patients with MG were centrifuged at 400 g for 5 min. Then 10× red blood cell lysis buffer (Solarbio, Beijing, China) was added to the cell precipitation, which was incubated on ice for 10 min to remove red blood cells. The cell pellets of thymic tissue and venous blood were resuspended in Hanks' buffer before the mononuclear cells were isolated using Ficoll-Paque (TBD, Tianjin, China) according to the manufacturer’s instructions.
ScRNA-seq library preparation and sequencing
The scRNA-seq library was prepared with the 10×Genomics Chromium single-cell protocol using the v3 reagent kit (10×Genomics, Pleasanton, CA, USA), according to the manufacturer’s instructions. 90 μl cellular suspension, 40 μl barcoded Single Cell 5′ Gel Beads, and 270 μl Partitioning Oil were loaded onto a Chromium Chip A to generate single-cell gel bead-in-emulsions (GEMs). GEM-reverse transcriptions (GEM-RTs) were performed in a Veriti 96-well thermal cycler (Thermo Fisher Scientific, Waltham, MA, USA) together with the RT master mix. After RT, cDNAs were amplified (98°C for 45 s; 13–18 cycles of 98°C for 20 s, 67°C for 30 s, 72°C for 1 min; and 72°C for 1 min) and then used for 5′ gene expression library construction with the Chromium Single Cell 5′ Library Construction Kit (10×Genomics, Pleasanton, CA, USA). The single-cell RNA library was sequenced on an Illumina NovaSeq 6000 with a read length of 150 bp paired-end reads.
ScRNA-seq data analysis
Cell filtering and quality control
For scRNA-seq raw data, Cell Ranger (v 6.0.1) provided by 10× Genomics with default parameters was used to align scRNA-seq reads to Homo_sapiens.GRCh38 reference genome. Then, unique molecular identifiers (UMIs) were mapped to the genes, and the barcodes were mapped to the cells. These indices were further analyzed using R library Seurat (v 4.3.0). Only genes expressed in at least 10 cells were retained. Low-quality cells were further excluded based on the following criteria: (i) fewer than 25 expressed genes; (ii) over 20% of UMIs mapped to mitochondrial or ribosomal genes; or (iii) less than 500 UMIs.
Cell clustering and visualization
We applied R library Seurat to perform unsupervised clustering of immune cells. Specifically, the NormalizedData function was used to normalize and scale the data, followed by the FindVariableGenes function to identify the 2000 highly variable genes (HVGs) within each sample with default parameters. Data from two MG patients and two HC subjects were independently combined for further analysis. After performing principal component analysis with these HVGs, the top 50 principal components and a resolution of 0.8 were selected for the following dimension reduction. Identified clusters were then annotated based on the expression of marker genes found using the FindAllMarkers function. Finally, four major immune cell populations were classified: B cells (MS4A1, CD79A, CD79B, IGHM, and IGHD), T cells (CD3D, CD3E, CD3G, CD2, and TRAC), natural killer (NK) cells (NKG7, KLRB1, GNLY, KLRD1, and CCL3), and myeloid cells (LYZ, CD14, FCGR3A, CD163, and CSF1R).
Gene expressional and functional analysis
R library DESeq2 (16) (v 1.26.0) was applied for specific cluster comparisons between MG patients and HCs. Genes with an absolute value of log2(fold change) greater than 0.25 and a P value lower than .05 were considered significantly differentially expressed genes (DEGs). Based on the DEGs between different clusters, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) functional enrichment analyses were conducted by R library clusterProfiler (v 4.8.1) (17).
Pseudotime trajectory analysis
The pseudotime developmental trajectories for CD4+ T cells and CD8+ T cells were constructed using R library Monocle3 (18) according to the standard workflow. After dimensionality reduction, cells were ordered in a temporal differentiation sequence based on the significant marker genes identified by FindAllMarkers function in Seurat.
RNA velocity analysis
The velocyto.py command-line tool (19) was used to annotate the spliced and unspliced reads from binary alignment/map files generated by Cell Ranger (v 6.0.1) software from 10× Genomics, with outputs stored as loom files. Specifically, GRCh38 reference genome annotation and expressed repeats annotation files were required to align reads to and mask expressed repetitive elements. Loom files were then processed using velocyto.R (v 0.6) to estimate RNA velocity based on gene structure parameters. The RNA velocity was visualized on the uniform manifold approximation and projection (UMAP) plot using Monocle DDRTree embedding method.
Interactions between cell types
Cell-cell interactions and key signaling pathways were investigated using CellChat (20). Quantitative contrasts and manifold learning were employed to identify signaling changes across distinct sample groups. After selecting potential signaling molecules that were perturbed or induced in MG patients, the official workflow in CellChat was followed with default parameters. Putative interaction pairs between crucial cell clusters in each group were then identified, and the results were visualized as circle plots.
Statistical analysis
The marker genes for transcriptional subpopulations were determined by the FindAllMarkers function in Seurat with the Wilcoxon rank-sum test. One-way analysis of variance followed by the Newman–Keuls post hoc test was employed to analyze the differences among multiple groups. The differences between paired samples were analyzed by the Wilcoxon signed-rank test, while the nonparametric Spearman test was used for correlation analysis. Statistical analyses and graphic processing were carried out by R. Unless otherwise stated, data are considered statistically significant in terms of *P < .05, **P < .01, and ***P < .001.
Results
Composition and classification of immune cells in thymus tissue and peripheral blood of MG patients
To explore the immune pathogenesis and the immune microenvironment of MG, we performed scRNA-seq to study the transcriptomic profiles of thymus tissue and PBMCs (MG-T and MG-B) in two patients with MG (Table 1) as well as PBMCs from two gender- and age-matched healthy controls (HC-B). After quality control and cell filtering, 23 846 and 9701 cells, respectively, originated from MG-T and MG-B, and 6930 cells from HC-B were used for analysis. According to the classical genetic markers, all immune cells were divided into four categories: T cells, B cells, myeloid cells, and NK cells (Fig. 1a and c), of which T cells accounted for the vast majority. Then, we compared the proportion of four immune cell groups in different samples. Because of the difficulty of obtaining absolutely normal thymus tissue intraoperatively, we cited data from other studies (a male donor aged 35–40) in the literature on thymus tissue from healthy controls (HC-T) as a control group (21). Obviously, each sample has a different frequency of cell distribution (Fig. 1b). The proportion of T cells in MG-T group (98.24%) was much higher than that in other groups including HC-T group (58.23%). Compared with HC-B group, the proportions of T cells and B cells were higher (64.93% vs. 55.90%, 11.62% vs. 4.60%) and the proportions of myeloid cells and NK cells were lower than those in MG-B group (8.61% vs. 12.82%, 14.85% vs. 26.68%). It can be seen that most of the DEGs were involved in T cell activation and differentiation signal pathways in both MG-T vs. MG-B group and MG-B vs. HC-B group, providing further evidence that the role of T cells in MG is primarily mediated by the activation of their functions, rather than merely by their numerical dominance in lesioned tissues (Fig. 1d). We further investigated cell-specific expression patterns of these MG-associated genes and found that the human leukocyte antigen (HLA) genes demonstrated the highest expression levels in MG-T cells, consistent with previous studies (22). Moreover, the predominant expression of HLA-DQB1, HLA-DRA, HLA-DRB1, and HLA-DQA1 in B cells and myeloid cells suggests that these cellular populations may form the cellular basis for antigen presentation and immune activation. Genes with the function of regulating T cell activation were most highly expressed in T cells (e.g. CTLA4 gene), while the expression levels of genes such as AP2B1, HSPA8, and AP1B1 were apparently different in the MG-T, MG-B, and HC-B groups (Fig. 1e).
Table 1.
Basic information of MG patients and HCs.
| Patient | Age | Sex | AChR antibody | Course | Thymic hyperplasia | Therapy |
|---|---|---|---|---|---|---|
| 1 | 35 | Male | 2.916 nmol/L | 1 mouth | Yes | None |
| 2 | 40 | Female | 4.285 nmol/L | 2 mouth | Yes | None |
| 3 | 37 | Male | ||||
| 4 | 41 | Female |
Course: time since diagnosis.
Figure 1.
ScRNA-seq of immune cells in thymus and peripheral blood from patients with MG and HCs. (a) The UMAP plots visually displayed the four cell types in each sample, and the color codes were carried out according to the cell type. MG-T represents thymus tissue from MG patients, MG-B represents PBMCs from MG patients, and HC-B represents PBMCs from HCs. (b) Cell proportion distribution of four types of cells in four different tissue samples. HC-T represents thymus tissue from HCs. (c) Canonical marker genes for the immune cell types defined in (b). Data are colored according to expression levels. (d) Gene ontology (GO) enrichment analysis of all the immune cells in both MG-T vs. MG-B group and MG-B vs. HC-B group (P value < .05). (e) Heatmap of differential expression levels of the MG-related genes across cell clusters in different samples.
Characterization of T cells derived from scRNA-seq data
We regrouped the T cells from MG-T, MG-B, and HC-B into four populations, including CD4+ T cells, CD8+ T cells, double-negative T cells (DNT), and double-positive T cells (DPT). On this basis, we focus on the analysis of CD4+ T cells and CD8+ T cells, in which CD4+ T cells can be further divided into naïve, effector CD4+ T/Tfh, Treg, and Tfh cells, CD8+ T cells can be divided into naïve, cytotoxic, and exhausted CD8+ T cells (Fig. 2a).
Figure 2.
Difference of transcriptional profiles in T cells between MG patients and HCs. (a) The UMAP plots of main clusters shown in different colors. CD4+ T cells: naïve cells; Effector CD4+ T/Tfh cells; Treg cells; Tfh cells, CD8+ T cells: naïve cells; cytotoxic cells; exhausted cells. (b) Average proportion of each T cell subtype derived from each sample, color-coded by cell types. (c) Color-coded for expression (blue to red) of marker genes for the clusters as indicated. (d) The differentiation trajectory map of CD4+CD8− cells and CD4−CD8+ cells (P value <0.05). (e) Dot plot of KEGG enrichment analysis of CD4+CD8− cells in MG-B vs. HC-B. (f) Dot plot of KEGG enrichment analysis of CD4−CD8+ cells in MG-B vs. HC-B (P value < .05).
The proportions of T cell subsets in MG-B and HC-B were very similar, but the proportions of T cell subsets in MG-T were apparently different from those of MG-B and HC-T groups. In particular, the proportions of naïve CD8+ T cells (40.62% vs. 18.19%, 40.62% vs. 0.12%) and DPT (41.14% vs. 1.17%, 41.14% vs. 0.11%) in MG-T were much higher than those in MG-B and HC-T groups, indicating that there were a large number of immature T cells in the thymus of patients with MG (Fig. 2b).
Figure 2c demonstrated that most of the marker genes were highly expressed only in their corresponding cluster. For instance, FOXP3 was a recognized marker gene in Treg cells, which was only highly expressed in CD4+ Treg cells, but had low expression in other clusters, which further proves the accuracy of cell clustering.
Then, we used the Monocle3 method to construct the differentiation trajectory of CD4+ T cells and CD8+ T cells. With the development of the differentiation process, CD4+CD8− T cells gradually developed from a naïve state to effector CD4+ T/Tfh, Treg, and Tfh states. However, almost all the CD4+CD8− T cells in MG-T remain in a naïve state, resulting in disruption of immune cell activation and differentiation processes (Fig. 2d, Supplementary Figure S1).
In CD4−CD8+ T cells, trajectory analysis revealed that naïve CD8+ T cells differentiated into cytotoxic CD8+ T cells in MG-B, while in MG-T, a small number of naïve CD8+ T cells differentiated into exhausted CD8+ T cells. This may contribute to the imbalance of thymic immune function in MG patients. In addition, the KEGG enrichment analysis of up-regulated and down-regulated genes of MG-B vs. HC-B showed CD4+ was highly correlated with NOD-like receptor signaling pathway and primary immunodeficiency, and CD8+ was highly correlated with NOD-like receptor signaling pathway and Fc gamma R-mediated phagocytosis, indicating that candidate signals are significantly enriched within MG peripheral blood T cells that may be involved in disease pathogenesis (Fig. 2e and f).
Characterization of B cells derived from scRNA-seq data
Similarly, we subdivided B cells into nine subgroups and named them according to the reported marker genes. These included four memory B cell clusters (0, 1, 2, 3), three naïve B cell clusters (4, 5, 6), and two plasma cell clusters (7, 8) (Fig. 3a and c).
Figure 3.
Difference of transcriptional profiles in B cells between MG patients and HCs. (a) The UMAP plots of main clusters shown in different colors: four memory B cell clusters (0, 1, 2, 3), three naïve B cell clusters (4, 5, 6), and two plasma cell clusters (7, 8). (b) Average proportion of each B cell subtype derived from each sample, color-coded by cell types. (c) Canonical marker genes for the B cell subtypes. Data are colored according to expression levels. (d) Volcano plot of differential gene expression analysis of B cells in MG-B and HC-B (P value < .05). (e) RNA velocity analysis of B cells across various samples. Colors indicate cell types and intermediate states, arrows show the average evaluated velocity.
Compared with HC-T, the proportion of memory B cells in MG-T increased (74.51% vs. 57.33%), while the number of naïve B cells decreased (14.52% vs. 23.55%). Similarly, compared with HC-B, the proportion of memory B cells in MG-B was observed to increase (51.46% vs. 39.57%), while the number of naïve B cells was observed to decrease (44.81% vs. 57.47%) (Fig. 3b). Meanwhile, compared with HC-B, we identified 460 up-regulated and 399 down-regulated genes of B cells in MG-B (Fig. 3d). Furthermore, RNA velocity analysis of B cells across various samples showed that the arrows in cluster 8 of MG-T and MG-B were longer than those of HC-B, indicating a higher presence of unspliced RNAs in this cell cluster of MG patients. It revealed that B cells in MG patients exhibited a more active state of differentiation (Fig. 3e).
Myeloid cell clustering analysis of MG patients and HCs
Next, myeloid cells were sub-grouped into seven clusters, including three classical monocytes (clusters 0, 1, and 3), nonclassical monocytes (clusters 2), intermediate monocytes (clusters 5), conventional dendritic cells (cDCs, clusters 4), and plasmacytoid dendritic cells (pDCs, clusters 6) (Fig. 4a). And, myeloid cells were apparently fewer in MG-T. The proportion of myeloid cell subtypes showed considerable heterogeneity (Fig. 4b). Compared to HC-B, MG-B showed an apparent decrease in classical monocytes (60.81% vs. 67.61%) and an apparent increase in non-classical monocytes (22.24% vs. 14.89%). DCs were predominant in HC-T (nearly 80%), whereas monocytes and DCs each accounted for 50% of the total in MG-T.
Figure 4.
Difference of transcriptional profiles in myeloid cells between MG patients and HCs. (a) The UMAP plots of main clusters shown in different colors: three classical monocytes (clusters 0, 1, and 3), nonclassical monocytes (clusters 2), intermediate monocytes (clusters 5), cDC (clusters 4), and pDC (clusters 6). (b) Average proportion of each myeloid cell subtype derived from each sample, color-coded by cell types. (c) Dot plot of the expression level of marker genes for monocytes and DCs. Data are colored according to expression level. (d) Volcano plot of differential gene expression analysis of myeloid cells in MG-B and HC-B (P value < .05). (e) Gene ontology (GO) enrichment analysis of myeloid cells using the genes dys-regulated in both MG-T vs. MG-B group and MG-B vs. HC-B group (P value < .05). (f) Heatmap of differential expression levels of the MG-related genes across monocytes and DCs in different samples.
Figure 4c demonstrated that the marker genes of monocytes and DCs were specifically highly expressed in the corresponding clusters. Compared with HC-B, we identified 854 up-regulated and 640 down-regulated genes of myeloid cells in MG-B. Moreover, the dys-regulated genes were mainly involved in the secretion of cytokines (Fig. 4d). The dys-regulated genes of MG-T vs. MG-B were mainly involved in antigen presentation and monocyte differentiation (Fig. 4e, Supplementary Figure S2). Furthermore, we analyzed the expression level of the MG-related genes in myeloid cell subpopulations and found that there was also cellular subpopulation heterogeneity (Fig. 4f). Genes such as HLA-DQA1, HLA-DQB1, HLA-DRA, and HLA-DRB1, whose expression was appreciably up-regulated in MG-T, were predominantly expressed in intermediate monocytes, and genes such as AP1S3 and AP1G1, which were appreciably over-expressed in the patients compared to controls, were predominantly distributed in pDCs.
Cell-to-cell communication network analysis among samples
In addition to intracellular information, scRNA-seq can also explore interactions between cells by integrating ligand and receptor information. We analyzed the possible interactions between the major immune cells in the MG patient group and the control group and found that monocytes interacted most strongly with other cells in the PBMCs of MG patients (Fig. 5a). Whereas in HC-B samples, plasma cells exhibited the strongest interactions with other cells, but this predominant effect was no longer observed in MG-B (Fig. 5b). Compared to MG-B, COMPLEMENT, XCR, and IFN-II signaling pathways were more enriched within MG-T (Fig. 5c). While CXCL, GAS, and CD30 signaling pathways were more enriched within MG-B compared with HC-B (Fig. 5d). Finally, we focused on analyzing the role of MG-related signaling pathways CD40 and the interleukin-16 (IL-16) pathway among various cell subpopulations. Compared with HC-B, Effector CD4+ T/Tfh cells and Treg cells interacted more strongly with NK cells and monocytes through CD40 signaling pathway, and this interaction of Treg cells was also reflected in MG-T. In MG-B and HC-B, the IL-16 signaling pathway is ubiquitous across cell populations, while in MG-T, this pathway communicates more strongly between T cells and B cells (Fig. 5e).
Figure 5.
Characterization of cell-to-cell signaling networks. (a) Heatmap of overall signaling among all cell populations in MG-T vs. MG-B. Positive values (red) indicate stronger interactions in MG-T, and negative values (blue) indicate stronger interactions in MG-B. (b) Heatmap of overall signaling among all cell populations in MG-B vs. HC-B. Positive values (red) indicate stronger interactions in MG-B, and negative values (blue) indicate stronger interactions in HC-B. (c) The information flow of significant signaling pathways in MG-T vs. MG-B. (d) The information flow of significant signaling pathways in MG-B vs. HC-B. (e) CD40 signaling pathway network and IL-16 signaling pathway network in MG-T, MG-B, and HC-B.
Discussion
MG is a T-cell-dependent autoimmune disease mediated by AChR antibodies (23, 24). In the present study, we are the first to provide a detailed molecular description of immune cells in MG patients at the single-cell level, charting differences in proportion and molecular state of immune cells in thymic tissue and blood.
During the period of embryonic development, the lymphatic progenitor cells experience the stages of differentiation from DNT to DPT in the thymus, and eventually differentiate into mature T cells with immune function, which only express CD4+ or CD8+ (25, 26). Then they leave the thymus and migrate to the surrounding lymphoid organs and exert the functions of cellular immunity and immune regulation (27). We found the proportions of naïve CD8+ T cells and DPT in MG-T were much higher than those in MG-B and HC-T groups. In addition, the differentiation trajectory demonstrated that almost all the CD4+CD8− T cells in MG-T remain in a naïve state. The naïve CD4+ T cells, naïve CD8+ T cells, and DPT cells are mature T cells that have never been stimulated by antigens. If the proportion of naïve cells is too large, it cannot play an effective role in cellular immunity and immune regulation, which may be one of the pathogenetic mechanisms of MG (28).
However, the differentiation of CD8+ T cells was slightly different from that of CD4 cells. Naïve CD8+ T cells differentiate into cytotoxic CD8+ T cells by short-term antigen stimulation, and then enter the peripheral blood to kill immune disorder cells, providing long-term protection for the human body (29). On the other hand, the naïve CD8+ T cells in the thymus gradually enter a state of dysfunction due to long-term exposure to antigens and inflammation, which is mainly characterized by the loss of killing function (30). Therefore, T cell exhaustion is a common feature of MG and will become a major target in immunotherapy.
Thus, overall, there were two characteristics of T cells in the thymic tissues of MG patients: (i) a high percentage of naïve CD8+ T cells and DPT, and almost all CD4+ T cells remained in the naïve state, suggesting that most of the T cells in the thymic tissues of MG patients were in the juvenile stage. The immune homeostasis was disrupted by the interruption of immune cell activation and differentiation processes; (ii) some naïve CD8+ T cells directly differentiated into exhausted CD8+ T cells, which may also contribute to the imbalance of immune function. KEGG enrichment analysis also further indicated that the thymus of MG patients affected MG through the involvement of T cells in multiple immune-related pathways.
No matter MG-B compared with HC-B, or MG-T compared with HC-T, the proportion of memory B cells was apparently increased, while the proportion of naïve B cells was apparently decreased. It is suggested that more naïve B cells in thymus tissue and peripheral blood of MG patients are stimulated by antigens and activated to differentiate into memory B cells, resulting in more rapid, more efficient, and more specific humoral immunity (31). RNA velocity analysis showed that naïve B cells in thymus tissue and blood of MG patients had a stronger tendency to differentiate into the plasma cell phenotype and a higher degree of activation, which may be related to the production of more AChR antibodies in MG patients and needs to be further confirmed by experiments such as flow cytometry.
We found that the monocytes and DCs in the thymus showed the greatest heterogeneity. First of all, the number of myeloid cells in the thymus was greatly reduced, which further proved that lymphocytes play a dominant role in the thymus. Secondly, DCs accounted for the vast majority of HC-T, while monocytes and DCs accounted for half of MG-T, in which the classical monocytes contributed to the host’s pro-inflammatory defense mechanism (32). At the same time, we found that compared with HC-B, the most significant signal pathway changes in MG patients were inflammation-related signal pathways, such as positive regulation of cytokine production, tumor necrosis factor production, and the type I interferon signal pathway. Therefore, the role of inflammation in the pathogenesis of MG cannot be ignored. The results of immune cell communication analysis also showed that monocytes interacted most with other cells in peripheral blood of MG patients, which further proved the role of monocytes in inflammatory pathways (33–35).
There are also some limitations in our study. First, the inadequate sample size of only two patients. The heterogeneities between thymus tissues and peripheral blood in MG patients need further verification with flow analysis and so on. Second, the absence of HC-T scRNA-seq data as a control, and the published healthy thymus scRNA-seq data could not be integrated with our own dataset because of the absence of raw data. Third, this study only conducted scRNA-seq, which did not perform experiments, such as flow cytometry or immunofluorescence, to verify the positive result of scRNA-seq.
Taken together, this preliminary study presents a comprehensive transcriptome map of immune cells in diseased tissues and peripheral blood of patients with MG at the single-cell level. Our study contributes to a better understanding of the underlying pathogenesis of MG, which is an interesting candidate for further studies addressing its potential role in the diagnosis and treatment of MG.
Supplementary Material
Contributor Information
Qingjun Wu, Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.
Yingyu Guo, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Liying Zhou, School of Life Science, Beijing Institute of Technology, Beijing 100081, China.
Yi Tian, Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.
Hanbo Yu, Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.
Ting Zhou, Department of Thoracic Surgery, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.
Siyuan Yin, Department of Anesthesiology and Surgery, Beijing Hospital, National Center of Gerontology; Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China.
Lihui Zou, The Key Laboratory of Geriatrics, Beijing Institute of Geriatrics, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology of National Health Commission, Beijing 100730, China.
Supplementary data
Supplementary data are available at International Immunology online.
Funding
This work was supported by the National High Level Hospital Clinical Research Funding (Grant BJ-2025-158, BJ-2023-077).
Data availability
The sequencing data presented in this study have been submitted to the Genome Sequence Archive (GSA) repository, with the accession number HRA013414. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Author contributions
Lih.Z. contributed to the design of the project. Y.T., H.Y., and T.Z provided clinical samples and relevant information. Y.G. performed sequencing and data analysis. S.Y. performed the validation of sequencing. Q.W. performed experiments and data analysis and wrote the manuscript. Liy.Z. performed the sequencing data analysis and figure preparation.
Ethics approval
The study was approved by the ethics committee of Beijing hospital (2023BJYYEC-222-02).
Consent to participate
All participants provided written informed consent.
Consent to publish
Obtained.
References
- 1. Salari N, Fatahi B, Bartina Y, et al. Global prevalence of myasthenia gravis and the effectiveness of common drugs in its treatment: a systematic review and meta-analysis. J Transl Med 2021;19:516. 10.1186/s12967-021-03185-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Goldstein G. Myasthenia gravis and the thymus. Annu Rev Med 1971;22:119–24. 10.1146/annurev.me.22.020171.001003 [DOI] [PubMed] [Google Scholar]
- 3. Wendell LC, Levine JM. Myasthenic crisis. Neurohospitalist 2011;1:16–22. 10.1177/1941875210382918 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Cron MA, Maillard S, Villegas J, et al. Thymus involvement in early-onset myasthenia gravis. Ann N Y Acad Sci 2018;1412:137–45. 10.1111/nyas.13519 [DOI] [PubMed] [Google Scholar]
- 5. Zdrojewicz Z, Pachura E, Pachura P. The Thymus: a forgotten, but very important organ. Adv Clin Exp Med 2016;25:369–75. 10.17219/acem/58802 [DOI] [PubMed] [Google Scholar]
- 6. Marx A, Pfister F, Schalke B, et al. The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes. Autoimmun Rev 2013;12:875–84. 10.1016/j.autrev.2013.03.007 [DOI] [PubMed] [Google Scholar]
- 7. Farmakidis C, Pasnoor M, Dimachkie MM, et al. Treatment of myasthenia gravis. Neurol Clin 2018;36:311–37. 10.1016/j.ncl.2018.01.011 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Ionescu L, Costea CF, Dănilă R, et al. Thymus pathology in myasthenia gravis with anti-acetylcholine receptor antibodies and concomitant Hashimoto’s thyroiditis. A four-case series and literature review. Rom J Morphol Embryol 2021;62:73–83. 10.47162/RJME.62.1.07 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Amin S, Aung M, Gandhi FR, et al. Myasthenia gravis and its association with thyroid diseases. Cureus 2020;12:e10248. 10.7759/cureus.10248 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Tanovska N, Novotni G, Sazdova-Burneska S, et al. Myasthenia gravis and associated diseases. Open Access Maced J Med Sci 2018;6:472–8. 10.3889/oamjms.2018.110 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Uzawa A, Kuwabara S, Suzuki S, et al. Roles of cytokines and T cells in the pathogenesis of myasthenia gravis. Clin Exp Immunol 2021;203:366–74. 10.1111/cei.13546 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Yi JS, Guptill JT, Stathopoulos P, et al. B cells in the pathophysiology of myasthenia gravis. Muscle Nerve 2018;57:172–84. 10.1002/mus.25973 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Yasumizu Y, Ohkura N, Murata H, et al. Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma. Nat Commun 2022;13:4230. 10.1038/s41467-022-31951-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Zhong H, Huan X, Zhao R, et al. Peripheral immune landscape for hypercytokinemia in myasthenic crisis utilizing single-cell transcriptomics. J Transl Med 2023;21:564. 10.1186/s12967-023-04421-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Jin W, Yang Q, Peng Y, et al. Single-cell RNA-Seq reveals transcriptional heterogeneity and immune subtypes associated with disease activity in human myasthenia gravis. Cell Discov 2021;7:85. 10.1038/s41421-021-00314-w [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014;15:550. 10.1186/s13059-014-0550-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Wu T, Hu E, Xu S, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb) 2021;2:100141. 10.1016/j.xinn.2021.100141 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Cao J, Spielman M, Qiu X, et al. The single-cell transcriptional landscape of mammalian organogenesis. Nature 2019;566:496–502. 10.1038/s41586-019-0969-x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Manno GL, Soldatov R, Zeisel A, et al. RNA velocity of single cells. Nature 2018;560:494–8. 10.1038/s41586-018-0414-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Jin S, Guerrero-Juarez CF, Zhang L, et al. Inference and analysis of cell-cell communication using CellChat. Nat Commun 2021;12:1088. 10.1038/s41467-021-21246-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Park JE, Botting RA, Domínguez Conde C, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science 2020;367:eaay3224. 10.1126/science.aay3224 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Zhong H, Zhao C, Luo S. HLA in myasthenia gravis: from superficial correlation to underlying mechanism. Autoimmun Rev 2019;18:102349. 10.1016/j.autrev.2019.102349 [DOI] [PubMed] [Google Scholar]
- 23. Gertel-Lapter S, Mizrachi K, Berrih-Aknin S, et al. Impairment of regulatory T cells in myasthenia gravis: studies in an experimental model. Autoimmun Rev 2013;12:894–903. 10.1016/j.autrev.2013.03.009 [DOI] [PubMed] [Google Scholar]
- 24. Ingelfinger F, Krishnarajah S, Kramer M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol 2021;141:901–15. 10.1007/s00401-021-02299-y [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Hagen M, Pangrazzi L, Rocamora-Reverte L, et al. Legend or truth: mature CD4+ CD8+ double-positive T cells in the periphery in health and disease. Biomedicines 2023;11:2702. 10.3390/biomedicines11102702 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Adu-Berchie K, Obuseh FO, Mooney DJ. T cell development and function. Rejuvenation Res 2023;26:126–38. 10.1089/rej.2023.0015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Weiskopf D, Weinberger B, Grubeck-Loebenstein B. The aging of the immune system. Transpl Int 2009;22:1041–50. 10.1111/j.1432-2277.2009.00927.x [DOI] [PubMed] [Google Scholar]
- 28. Appay V, Sauce D. Naive T cells: the crux of cellular immune aging? Exp Gerontol 2014;54:90–3. 10.1016/j.exger.2014.01.003 [DOI] [PubMed] [Google Scholar]
- 29. Giles JR, Ngiow SF, Manne S, et al. Shared and distinct biological circuits in effector, memory and exhausted CD8(+) T cells revealed by temporal single-cell transcriptomics and epigenetics. Nat Immunol 2022;23:1600–13. 10.1038/s41590-022-01338-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Zhang N, Bevan MJ. CD8(+) T cells: foot soldiers of the immune system. Immunity 2011;35:161–8. 10.1016/j.immuni.2011.07.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Zhu X, Hong S, Bu J, et al. Antiviral memory B cells exhibit enhanced innate immune response facilitated by epigenetic memory. Sci Adv 2024;10:eadk0858. 10.1126/sciadv.adk0858 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Sathler-Avelar R, Vitelli-Avelar DM, Mattoso-Barbosa AM, et al. Phenotypic features of circulating leukocytes from non-human primates naturally infected with trypanosoma cruzi resemble the Major immunological findings observed in human chagas disease. PLoS Negl Trop Dis 2016;10:e0004302. 10.1371/journal.pntd.0004302 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Tellier J, Nutt SL. Plasma cells: the programming of an antibody-secreting machine. Eur J Immunol 2019;49:30–7. 10.1002/eji.201847517 [DOI] [PubMed] [Google Scholar]
- 34. Cyster JG, Allen CD. B cell responses: cell interaction dynamics and decisions. Cell 2019;177:524–40. 10.1016/j.cell.2019.03.016 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Shi C, Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol 2011;11:762–74. 10.1038/nri3070 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The sequencing data presented in this study have been submitted to the Genome Sequence Archive (GSA) repository, with the accession number HRA013414. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.





